About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Trial of DFP-14927 in Advanced Solid Tumors | Clinical Trials | Clareo Health

RECRUITINGPhase 1

Trial of DFP-14927 in Advanced Solid Tumors

A Phase I Study of DFP-14927 in Patients With Advanced Solid Tumors

NCT03943004•Delta-Fly Pharma, Inc.

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Solid TumorCancer

Interventions

DFP-14927

Locations

2

United States

Locations (2)

UCLA Department of Medicine- Hematology/Oncology

Los Angeles, California, United States

MD Anderson Cancer Center

Houston, Texas, United States

Key Dates

Start Date

September 30, 2019

Primary Completion Date

March 1, 2026

Completion Date

June 1, 2026

Last Updated

March 3, 2025

Related Studies

RECRUITINGPhase 1

Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial

NCT04704661

Advanced Breast CarcinomaAdvanced Colon Carcinoma+38 more

RECRUITINGPhase 2

Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer

NCT04929028

AIDS-Related Anal CarcinomaAnal Margin Squamous Cell Carcinoma+8 more

Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease

NCT00026884

Malignant NeoplasmsHereditary Neoplastic Syndromes+3 more

RECRUITINGPhase 2

Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations

NCT04550494

Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8+29 more

En-bloc Transurethral Resection of Bladder Tumor (En-bloc TURBT) Specimens Using a Redesigned Surgical Resectoscope Device

NCT04235764

RECRUITINGPhase 2

Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung Cancer

NCT05198830

Lung AdenocarcinomaLung Large Cell Carcinoma+2 more

View all related studies

Sponsors

Lead Sponsor

Delta-Fly Pharma, Inc.

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 3, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions